✦ LIBER ✦

Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy

✍ Scribed by Suarez-Almazor, Maria E.; Peddi, Prashanth; Luo, Ruili; Nguyen, Hoang T.; Elting, Linda S.

Book ID: 121579311
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 184 KB
Volume: 22
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-013-2008-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Alendronate on Bone Mineral D

Effects of Alendronate on Bone Mineral Density in Men with Prostate Cancer Treated with Androgen Deprivation Therapy

✍ Bruder, Jan M.; Ma, J.Z.; Wing, N.; Basler, J.; Katselnik, D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Zoledronic Acid Initiated During the Fir

Zoledronic Acid Initiated During the First Year of Androgen Deprivation Therapy Increases Bone Mineral Density in Patients With Prostate Cancer

✍ Ryan, Christopher W.; Huo, Dezheng; Demers, Laurence M.; Beer, Tomasz M.; Lacern 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 231 KB

Management of decreased bone mineral den

Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer

✍ Abbas H. Panju; Henriette Breunis; Angela M. Cheung; Marc Leach; Neil Fleshner; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Bone Loss after Initiation of Androgen D

Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer

✍ Greenspan, Susan L.; Coates, Penelope; Sereika, Susan M.; Nelson, Joel B.; Trump 📂 Article 📅 2005 🏛 Endocrine Society 🌐 English ⚖ 251 KB

Re: Zoledronic Acid Initiated During the

Re: Zoledronic Acid Initiated During the First Year of Androgen Deprivation Therapy Increases Bone Mineral Density in Patients With Prostate Cancer

✍ Gilbert, Scott M.; Dunn, Rodney L.; Wei, John T. 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

MP-22.12: The effect of risedronate for

MP-22.12: The effect of risedronate for prostate cancer patients with lower bone mineral density under androgen-deprivation therapy

✍ K. Ishizaka; T. Machida; N. Kanbe; M. Miyao; Y. Mizuno; S. Masuda; T. Kamai; K. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 89 KB